CEE doesn't increase Br Ca risk in women without a uterus

Article

Long-term treatment with conjugated equine estrogens (CEE) does not increase the risk of breast cancer in postmenopausal women who have had a prior hysterectomy, but it may increase the likelihood that mammographic screening results would require short-interval follow-up, according to the latest data from the Women's Health Initiative Estrogen-Alone trial.

Long-term treatment with conjugated equine estrogens (CEE) does not increase the risk of breast cancer in postmenopausal women who have had a prior hysterectomy, but it may increase the likelihood that mammographic screening results would require short-interval follow-up, according to the latest data from the Women's Health Initiative Estrogen-Alone trial.

The 40-center trial, involving over 10,000 women between the ages of 50 and 79, compared 7 years of 0.625 mg/d CEE to placebo. The researchers calculated hazard ratios for invasive breast cancer and for ductal carcinomas for women assigned to CEE versus placebo to be 0.80 (95% CI; 0.62–1.04; P=0.09) and 0.71 (95% CI; 0.52–0.99; P=0.054), respectively. In other words, rates of breast cancer either did not differ significantly between the two groups or were actually slightly lower for certain subtypes of cancer in the treated arm.

At 1 year, however, 9.2% of the women taking CEE had abnormalities on mammography that required follow-up versus 5.5% of the placebo group (P<0.001). By 7 years, 36.2% of the CEE group versus 28.1% of the placebo group required short-interval mammographic follow-up (P<0.001).

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Related Content
© 2025 MJH Life Sciences

All rights reserved.